Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.

The American Journal of Medicine
Amanda J Redig, Hidayatullah G Munshi

Abstract

Emerging evidence implicates metabolic syndrome as a long-term cancer risk factor but also suggests that certain cancer therapies might increase patients' risk of developing metabolic syndrome secondary to cancer therapy. In particular, breast cancer and prostate cancer are driven in part by sex hormones; thus, treatment for both diseases is often based on hormone-modifying therapy. Androgen suppression therapy in men with prostate cancer is associated with dyslipidemia, increasing risk of cardiovascular disease, and insulin resistance. Anti-estrogen therapy in women with breast cancer can affect lipid profiles, cardiovascular risk, and liver function. As the number of cancer survivors continues to grow, treating physicians must be aware of the potential risks facing patients who have been treated with either androgen suppression therapy or anti-estrogen therapy so that early diagnosis and intervention can be achieved.

References

Jul 25, 1992·BMJ : British Medical Journal·J A DewarR A Wood
Dec 1, 1991·Annals of Internal Medicine·R R LoveD L DeMets
Mar 16, 1989·The New England Journal of Medicine·D W Foster
Nov 1, 1985·The Journal of Clinical Endocrinology and Metabolism·E FrazeG M Reaven
Feb 13, 2001·Annual Review of Medicine·A Dunaif, A Thomas
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 19, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M C NguyenJ G Kral
Jan 16, 2002·JAMA : the Journal of the American Medical Association·Earl S FordWilliam H Dietz
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rowan T ChlebowskiAnne McTiernan
Dec 31, 2005·The New England Journal of Medicine·UNKNOWN Breast International Group (BIG) 1-98 Collaborative GroupAron Goldhirsch
Jun 27, 2006·Fertility and Sterility·Andrea Dunaif
Aug 5, 2006·The Lancet Oncology·UNKNOWN Arimidex, Tamoxifen, Alone or in Combination Trialists' GroupJ M Nabholtz
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Milena Braga-BasariaShehzad Basaria
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingMatthew R Smith
Jan 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan S CoatesAron Goldhirsch
Jun 15, 2007·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Bruno Lunenfeld
Jul 28, 2007·Cancer·Christopher S SaigalUNKNOWN Urologic Diseases in America Project
Oct 11, 2007·Journal of the National Cancer Institute·Henry K TsaiPeter R Carroll
Nov 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henning MouridsenAron Goldhirsch
Dec 22, 2007·Journal of Clinical Gastroenterology·Chiara GabbiNicola Carulli
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pamela J Goodwin
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A LigibelEric P Winer
Apr 10, 2008·Journal of the National Cancer Institute·Karyn Hede
Apr 24, 2008·Nature Clinical Practice. Urology·Daniel A GalvãoNigel Spry
Jul 26, 2008·Postgraduate Medicine·Hima Boppidi, Sumanth R Daram
Nov 15, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Trond M MichelsenAnne Dørum
Dec 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Raj Vuppalanchi, Naga Chalasani
Dec 17, 2008·American Journal of Obstetrics and Gynecology·Ruchi MathurRicardo Azziz
Mar 17, 2009·Metabolic Syndrome and Related Disorders·Pooja PothiwalaSubhashini Yaturu
Apr 4, 2009·Journal of Andrology·Abdulmaged M TraishAndre Guay

❮ Previous
Next ❯

Citations

Aug 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kyae Hyung KimSang Min Park
Nov 8, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E C de HaasJ A Gietema
Jun 1, 2012·Journal of Gastroenterology and Hepatology·Takafumi TamuraNobuhiro Ohkohchi
Apr 28, 2012·Diabetology & Metabolic Syndrome·Shi-Sheng ZhouJi-Min Cao
Apr 11, 2013·International Journal of Cell Biology·Jennifer H GunterColleen C Nelson
May 2, 2012·Advances in Urology·Jennifer H GunterColleen C Nelson
Jan 11, 2014·Endocrine·Katherine EspositoDario Giugliano
Aug 3, 2014·Seminars in Oncology Nursing·Jessica Shank Coviello
May 25, 2013·Clinical Genitourinary Cancer·Vincenza ConteducaMichele Aieta
Jun 27, 2015·Endocrine-related Cancer·Amanda SchechGauri Sabnis
Sep 13, 2011·Cell Metabolism·Rodrigo P A Barros, Jan-Åke Gustafsson
Jul 29, 2015·EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [et Al.]·Berthe M P AlemanSarah C Darby
Jan 28, 2015·Nutrition and Cancer·Abhimanyu GhoseIman Mohamed
Jun 2, 2017·Climacteric : the Journal of the International Menopause Society·P Ferreira PoloniE Aguiar Petri Nahas
Jan 4, 2017·Endocrine·Lorenzo ScappaticcioKatherine Esposito
Dec 7, 2016·Cancer Nursing·Su Jung Lee, Nam Cho Kim
Jul 13, 2013·Journal of Psychosocial Oncology·Gregory P BeehlerLynn Steinbrenner
Jul 25, 2015·Phytotherapy Research : PTR·Walter ChingwaruJose Jackson
Jul 13, 2011·Cancer Research·Amy A LubikColleen C Nelson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.